# Clinical Pharmacokinetics

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/clinical-pharmacokinetics/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 0312-5963 |
| ISSNs | 0312-5963,1179-1926 |
| OpenAlex ID | https://openalex.org/S69290020 |
| Publisher | Adis, Springer Healthcare |

## Journal papers

Showing 12 of 16.

- [Quantification of Lean Bodyweight](https://scholariq.org/papers/quantification-of-lean-bodyweight/)
- [Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids](https://scholariq.org/papers/pharmacokinetics-and-pharmacodynamics-of-systemically-administered/)
- [Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs](https://scholariq.org/papers/mechanism-based-inhibition-of-cytochrome-p450-3a4-by-therapeutic-drugs/)
- [The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients](https://scholariq.org/papers/the-effects-of-hypoalbuminaemia-on-optimizing-antibacterial-dosing-in-critically/)
- [Pharmacogenetics of Warfarin Elimination and its Clinical Implications](https://scholariq.org/papers/pharmacogenetics-of-warfarin-elimination-and-its-clinical-implications/)
- [Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2](https://scholariq.org/papers/clinical-pharmacokinetics-and-pharmacodynamics-of-dapagliflozin-a-selective/)
- [The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations](https://scholariq.org/papers/the-first-in-class-potassium-competitive-acid-blocker-vonoprazan-fumarate/)
- [Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem](https://scholariq.org/papers/clinical-pharmacokinetics-of-verapamil-nifedipine-and-diltiazem/)
- [Drug-Drug Interaction Profiles of Proton Pump Inhibitors](https://scholariq.org/papers/drug-drug-interaction-profiles-of-proton-pump-inhibitors/)
- [Pharmacokinetic Interactions of Antimalarial Agents](https://scholariq.org/papers/pharmacokinetic-interactions-of-antimalarial-agents/)
- [Exposure–Toxicity Relationship of Sorafenib in Japanese Patients with Renal Cell Carcinoma and Hepatocellular Carcinoma](https://scholariq.org/papers/exposure-toxicity-relationship-of-sorafenib-in-japanese-patients-with-renal-cell/)
- [Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 2, Drugs Administered Orally)](https://scholariq.org/papers/clinical-pharmacokinetics-of-drugs-in-patients-with-heart-failure-an-update-part/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.